Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Acumen Pharmaceuticals, Inc. | CFO & Chief Business Officer | Common Stock | 211K | $734K | $3.47 | Jan 18, 2024 | Direct |
Acumen Pharmaceuticals, Inc. | CFO & Chief Business Officer | Employee Stock Option (right to buy) | 159K | Jan 2, 2024 | Direct | ||
ELUTIA INC. | Director, 10%+ Owner | Stock Option (Right to Buy) | 31.8K | Jun 6, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ELUT | ELUTIA INC. | Jun 6, 2024 | 1 | $0 | 4 | Jun 10, 2024 | Director, 10%+ Owner |
ABOS | Acumen Pharmaceuticals, Inc. | Jan 18, 2024 | 1 | -$15.7K | 4 | Jan 19, 2024 | CFO & Chief Business Officer |
ABOS | Acumen Pharmaceuticals, Inc. | Jan 2, 2024 | 2 | $0 | 4 | Jan 4, 2024 | CFO & Chief Business Officer |
ABOS | Acumen Pharmaceuticals, Inc. | Jan 17, 2023 | 2 | $0 | 4 | Jan 18, 2023 | CFO and Chief Business Officer |
ABOS | Acumen Pharmaceuticals, Inc. | Dec 29, 2022 | 2 | $59.5K | 4 | Jan 3, 2023 | CFO and Chief Business Officer |
ABOS | Acumen Pharmaceuticals, Inc. | Jan 19, 2022 | 1 | $0 | 4 | Jan 21, 2022 | CFO and Chief Business Officer |
ABOS | Acumen Pharmaceuticals, Inc. | Jul 6, 2021 | 3 | $0 | 4 | Jul 8, 2021 | Chief Financial Officer |
ABOS | Acumen Pharmaceuticals, Inc. | Jun 30, 2021 | 0 | $0 | 3 | Jun 30, 2021 | Chief Financial Officer |